VertexPharma wants to transform the treatment of pain. An upcoming sciatica clinical trial readout will be pivotal.

The Boston biotech plans to announce results by the end of the year from a mid-stage trial of an experimental treatment for patients with lumbosacral radiculopathy, or LSR, more commonly known as ...